Symbol="RPHM"
AssetType="Common Stock"
Name="Reneo Pharmaceuticals Inc"
Description="Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on developing therapies for patients with rare genetic mitochondrial diseases. The company is headquartered in San Diego, California."
CIK="1637715"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="18575 JAMBOREE ROAD, SUITE 275-S, IRVINE, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="218776000"
EBITDA="-56846000"
PERatio="None"
PEGRatio="None"
BookValue="3.468"
DividendPerShare="0"
DividendYield="0"
EPS="-1.96"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.293"
ReturnOnEquityTTM="-0.486"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-1.96"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="25"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.469"
EVToRevenue="-"
EVToEBITDA="1.249"
Beta="1.071"
num_52WeekHigh="11.29"
num_52WeekLow="1.79"
num_50DayMovingAverage="7.28"
num_200DayMovingAverage="5.18"
SharesOutstanding="33657800"
DividendDate="None"
ExDividendDate="None"
symbol="RPHM"
open="6.41"
high="6.50"
low="6.03"
price="6.22"
volume="94617.00"
latest_trading_day="2023-08-11"
previous_close="6.50"
change="-0.28"
change_percent="-4.3077%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="26"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="74"
Volume_recent_avg="142130"
Change_recent_avg="-0.01"
Delta_recent_avg="0.81"
Variance_recent_avg="0.4"
Change_ratio_recent_avg="-0.37"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="74"
Aroon_momentum_negative="26"
image_negative_thumbnail_id_1="497"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0108.jpeg"
image_negative_thumbnail_id_2="492"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0113.jpeg"
image_neutral_thumbnail_id_1="555"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0044.jpeg"
image_neutral_thumbnail_id_2="566"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0033.jpeg"
image_positive_thumbnail_id_1="682"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0026.jpeg"
image_positive_thumbnail_id_2="998"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0160.jpeg"
image_professor_thumbnail_id_1="1197"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0031.jpeg"
image_professor_thumbnail_id_2="1171"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0005.jpeg"
